Pancreatic cancer and diabetes risk after surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies how pancreatic cancer affects blood sugar and the risk of developing diabetes after surgery. Patients who have their pancreas removed will provide blood and tissue samples to help understand this link.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Chinese man or woman.
- You are 18 years or older.
- You have pancreatic cancer and your doctor plans to remove part or all of your pancreas.
- You have not been diagnosed with diabetes or prediabetes before, and your blood sugar and A1C levels are normal.
- You are not pregnant, nursing, or taking medicines that could cause diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies pancreatic islets (cells that make insulin) from people who are having part or all of their pancreas removed. It may help researchers learn more about how the pancreas works in health and disease.
This study looks at how tiny particles in blood (“exosomes”) carry signals between cells in people having pancreatic surgery. The goal is to understand these signals in different pancreatic conditions and treatment situations, which may help future care.
This study looks at how well blood sugar (glucose) levels can be monitored and managed in people with pancreatic cancer who are starting their first treatment. It aims to understand if careful glucose management can improve well-being and possibly treatment outcomes.
This study looks at your immune system before pancreatic surgery to predict if you might develop a common post-surgery complication called a pancreatic leak (where digestive juices escape the pancreas). The goal is to see if simple blood tests before surgery can help doctors plan better care and reduce risks for future patients.
This study looks at people recently diagnosed with type 2 diabetes to check their pancreas health using blood tests and scans. The goal is to find early signs of pancreatic issues, which might help catch problems sooner.
This study uses a special blood test to look for tiny amounts of cancer DNA after your pancreatic cancer surgery. It may help doctors see early if the cancer is coming back, so they can act sooner.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.